SP-96

SP-96 is a potent, selective and non-ATP-competitive inhibitor of Aurora B with IC50 of 0.316 nM. SP-96 can be used for the research of triple negative breast cancer (TNBC).

SP-96 Chemical Structure

SP-96 Chemical Structure

CAS No. 2682114-54-9

Purity & Quality Control

Batch: S965801 DMSO]91 mg/mL]false]Ethanol]2 mg/mL]false]Water]Insoluble]false Purity: 99.77%
99.77

SP-96 Related Products

Biological Activity

Description SP-96 is a potent, selective and non-ATP-competitive inhibitor of Aurora B with IC50 of 0.316 nM. SP-96 can be used for the research of triple negative breast cancer (TNBC).
Targets
Aurora B [1]
(Cell-free assay)
0.316 nM
In vitro
In vitro

SP-96 shows sub-nanomolar potency in Aurora B enzymatic assays (IC50 = 0.316 ± 0.031 nM). SP-96 shows >2000 fold selectivity against FLT3 and KIT which is important for normal hematopoiesis. Enzyme kinetics of SP-96 shows non-ATP competitive inhibition which makes it a first-in-class inhibitor. SP-96 shows selective growth inhibition in NCI60 screening, including inhibition of MDA-MD-468, a Triple Negative Breast Cancer cell line.[1]

Kinase Assay Aurora Kinase B enzymatic assay
Kinase inhibition assay is done by measuring kinase activity in a microfluidics assay. The separation of a phosphorylated product from substrate is monitored. The assay is run using a 12-sipper chip on a Caliper EZ Reader II. The recipe used for separation buffer is 100 mM HEPES, 10 mM EDTA, 0.015% Brij-35, 0.1% CR-3. The compound stocks (20 mM in DMSO) are diluted into kinase buffer. 1 μL of desired stock solution is transferred into a 384-well microtiter assay plate. The Aurora B enzyme is diluted in kinase buffer to a concentration of 2 nM. 5 μL of the enzyme mixture is transferred to the assay plate. The inhibitors/Aurora B enzyme are incubated for 60 min with minor shaking. A substrate mix is prepared containing ATP and 5FAM tagged peptide dissolved in kinase buffer described above. 5 μL of the substrate solution is added to the assay plate. Running concentrations are as follows: peptide (1.5 μM), ATP (190 μM), and compound 12-point ½log dilutions (0.2 mM-0.632 nM). No inhibitor is added for positive control, and no enzymewas added for negative control. For running control, barasertib is used. Percentage inhibition is measured by comparing starting peptide to phosphorylated productpeaks.
Cell Research Cell lines MCF-7 cells
Concentrations --
Incubation Time 24 h
Method

The growth inhibition of 60 cell lines is obtained by submitting the compound to National Cancer Institute’s NCI60 panel. MCF-7 cells are cultured in RPMI-1640 medium with 5% FBS in an incubator maintained at 37 ℃ and 5% CO2. The media is changed on alternate days. After reaching confluency, the media is aspirated, cells are washed with PBS, detached using 0.25% trypsin and centrifuged. The collected cells are seeded in 96-well microtiter plates at a density of 5000 cells/well. The cells are allowed to adhere to plate overnight. The test compounds, vehicle control and positive controls are added 24 h after the cells are plated and allowed to incubate. Following 24 h of incubation, the media is aspirated, and the cells are washed with PBS. 40 mL of the media and 10 mL of 5 mg/mL of MTT solution prepared in PBS is added to the cells and incubated for 4 h at 37 ℃ and 5% CO2. After incubation, 150 mL of DMSO is added to each well and the cell viability is measured at 570 nM by an ELISA plate reader.

Chemical Information & Solubility

Molecular Weight 453.47 Formula

C25H20FN7O

CAS No. 2682114-54-9 SDF --
Smiles CC1N=CC(=N1)C2=CC=C3C(=NC=NC3=C2)NC4=CC=CC(=C4)NC(=O)NC5=CC(=CC=C5)F
Storage (From the date of receipt) 3 years -20°C powder

In vitro
Batch:

DMSO : 91 mg/mL ( (200.67 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 2 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy SP-96 | SP-96 supplier | purchase SP-96 | SP-96 cost | SP-96 manufacturer | order SP-96 | SP-96 distributor